KLI

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial

Metadata Downloads
Publisher
LANCET ONCOLOGY
Language
영어
ISSN
1470-2045
Citation Volume
21
Citation Number
8
Citation Start Page
1066
Citation End Page
1076
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.